M.A. Karsdal

Active 2000–2025

328
Papers
25,650
Citations
93
h-index
305
i10-index

Citations

Citations per year for M.A. Karsdal1982: 1 citations1984: 1 citations2000: 1 citations2001: 1 citations2002: 4 citations2003: 16 citations2004: 34 citations2005: 47 citations2006: 70 citations2007: 60 citations2008: 84 citations2009: 116 citations2010: 112 citations2011: 156 citations2012: 152 citations2013: 178 citations2014: 172 citations2015: 201 citations2016: 213 citations2017: 227 citations2018: 249 citations2019: 803 citations2020: 1,149 citations2021: 1,407 citations2022: 1,133 citations2023: 895 citations2024: 1,592 citations2025: 934 citations2026: 36 citations1983: no citations, so this year is not shown1985–1999: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,055 citing papers, 18.5% of this breakdownChina: 1,518 citing papers, 13.6% of this breakdownUnited Kingdom: 865 citing papers, 7.8% of this breakdownGermany: 630 citing papers, 5.7% of this breakdownDenmark: 570 citing papers, 5.1% of this breakdownItaly: 460 citing papers, 4.1% of this breakdownAustralia: 373 citing papers, 3.4% of this breakdownFrance: 370 citing papers, 3.3% of this breakdownNetherlands: 350 citing papers, 3.1% of this breakdownSpain: 339 citing papers, 3% of this breakdownCanada: 311 citing papers, 2.8% of this breakdownJapan: 240 citing papers, 2.2% of this breakdown
0%18.5%Other 27.4%

Fields

  • Medicine65.8%
  • Biochemistry, Genetics and Molecular Biology22.6%
  • Immunology and Microbiology2.7%
  • Engineering1.9%
  • Neuroscience1.5%
  • Materials Science1.2%
  • Other4.3%

Topics

  • Osteoarthritis Treatment and Mechanisms6.7%
  • Liver Disease Diagnosis and Treatment4.7%
  • Bone Metabolism and Diseases3%
  • Rheumatoid Arthritis Research and Therapies2%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis1.7%
  • Bone health and treatments1.7%
  • Other80.2%

Coauthors

All papers

Open in search
  1. Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guruprasad P. Aithal, Jörn M. Schattenberg, Elisabetta Bugianesi, Manuel Romero‐Gómez, Vlad Ratziu, Quentin M. Anstee, Patrick M. Bossuyt - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 196

  2. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Vlad Ratziu, Karine Clément, Raluca Pais, Detlef Schuppan, Jörn M. Schattenberg, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas, Evangelia Petsalaki, Matej Orešič, Tuulia Hyötyläinen, Aiden McGlinchey, José M. Mato, Óscar Millet, Jean‐François Dufour, Annalisa Berzigotti, Michael Pavlides, Stephen A. Harrison, Stefan Neubauer, Jeremy Cobbold, Ferenc E. Mózes, Salma Akhtar, Rajarshi Banerjee, Matt Kelly, Elizabeth Shumbayawonda, Andrea Dennis, Charlotte Erpicum, Manuel Romero‐Gómez, Emilio Gómez-González, Javier Ampuero, Javier Castell, Rocío Gallego‐Durán, Isabel Fernández-Lizaranzu, Rocío Montero‐Vallejo, M.A. Karsdal, Elisabeth Erhardtsen, Daniel Guldager Kring Rasmussen, Diana Julie Leeming, Mette Juul Fisker, Antonia Sinisi, Kishwar Musa, Fay Betsou, Estelle Sandt, Manuela Tonini, Elisabetta Bugianesi, Chiara Rosso, Angelo Armandi, Fabio Marra, Amalia Gastaldelli, Gianluca Svegliati, Jérôme Boursier, Sven Francque, Luisa Vonghia, Mattias Ekstedt, Stergios Kechagias, Hannele Yki‐Järvinen, Panu K. Luukkonen, Saskia W. C. van Mil, George Papatheodoridis, Helena Cortez‐Pinto, Luca Valenti, Salvatore Petta, Luca Miele, Andreas Geier and 35 more - Journal of Hepatology 2021 cited by 353

  3. The good and the bad collagens of fibrosis – Their role in signaling and organ function

    Authors: , , , , , , , , , , , , - Advanced Drug Delivery Reviews 2017 cited by 502

  4. Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology

    Authors: , , - Journal of Experimental & Clinical Cancer Research 2019 cited by 495

  5. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use

    Authors: , , , , - Osteoarthritis and Cartilage 2015 cited by 653

  6. Recent advances in understanding the phenotypes of osteoarthritis

    Authors: , , , , , - F1000Research 2019 cited by 214

  7. Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: lessons learned from failures and opportunities for the future

    Authors: , , , , , , , , , - Osteoarthritis and Cartilage 2016 cited by 384

  8. BMS‐986263 in patients with advanced hepatic fibrosis: 36‐week results from a randomized, placebo‐controlled phase 2 trial

    Authors: , , , , , , , , , , , - Hepatology 2021 cited by 100

  9. Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2021 cited by 141

  10. Collagen‐mediated hemostasis

    Authors: , , - Journal of Thrombosis and Haemostasis 2016 cited by 228

  11. The minor collagens in articular cartilage

    Authors: , , , , , , , - Protein & Cell 2017 cited by 261

  12. ADAPT: An Algorithm Incorporating PRO‐C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis

    Authors: , , , , , , , , , , , , , , , , , - Hepatology 2018 cited by 257

  13. Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix

    Authors: , , , , - Frontiers in Immunology 2023 cited by 65

  14. The collagen landscape in cancer: profiling collagens in tumors and in circulation reveals novel markers of cancer‐associated fibroblast subtypes

    Authors: , , , , , , - The Journal of Pathology 2023 cited by 92

  15. Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peer Bork, Mathias Mann, Jelle Matthijnssens, Aleksander Krag, Torben Hansen - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 75

  16. Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial

    Authors: , , , , , , , , , , , , , , , , , - Journal of Hepatology 2018 cited by 180

  17. Dermal fibroblasts have different extracellular matrix profiles induced by TGF-β, PDGF and IL-6 in a model for skin fibrosis

    Authors: , , , , , , - Scientific Reports 2020 cited by 125

  18. Novel insights into the function and dynamics of extracellular matrix in liver fibrosis

    Authors: , , , , , , , , , , , , , - American Journal of Physiology-Gastrointestinal and Liver Physiology 2015 cited by 269

  19. Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease

    Authors: , , , , , , , , , , , , , , , - JHEP Reports 2019 cited by 132

  20. Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction

    Authors: , , , , , , , , , , , , , , , , , , - eLife 2021 cited by 84

  21. Value of biomarkers in osteoarthritis: current status and perspectives

    Authors: , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2013 cited by 325

  22. Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study

    Authors: , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2015 cited by 324

  23. Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort

    Authors: , , , , , , , , , , , , , , , , - Respiratory Research 2019 cited by 142

  24. Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Torben Hansen, Matthias Mann, Jelle Matthijnssens, Aleksander Krag, Aleksander Krag, Peer Bork, Torben Hansen, Manimozhiyan Arumugam, Jonel Trebicka, M.A. Karsdal, Ema Anastasiadou, Hans Israelsen, Hans Olav Melberg, Cristina Legido‐Quigley, Maja Thiele - Journal of Hepatology 2024 cited by 57